We are live on ! Find out more
GCM

Glenview Capital Management Portfolio holdings

AUM $5.49B
1-Year Est. Return 46.89%
This Fund
S&P 500
This Quarter Est. Return
+4.68%
1 Year Est. Return
+46.89%
3 Year Est. Return
+94.27%
5 Year Est. Return
+129.04%
10 Year Est. Return
+529.98%
AUM
$15.4B
AUM Growth
+$340M
Cap. Flow
-$287M
Cap. Flow %
-1.86%
Top 10 Hldgs %
49.75%
Holding
58
New
6
Increased
22
Reduced
15
Closed
6
Avg Time Held Equity + Options
6.9 quarters
Top 10 Avg Time Held Equity + Options
2.5 quarters
Top 20 Avg Time Held Equity + Options
7.2 quarters
Avg Time Held Equity only
6.9 quarters
Top 10 Avg Time Held Equity only
2.5 quarters
Top 20 Avg Time Held Equity only
7.2 quarters

Top Buys

Rank Stock Value
1
DXC icon
DXC Technology
DXC
+$626M
2
EBAY icon
eBay
EBAY
+$249M
3
FMC icon
FMC
FMC
+$179M
4
IQV icon
IQVIA
IQV
+$171M
5
APTV icon
Aptiv
APTV
+$155M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$1.04B
2
CSC
Computer Sciences
CSC
+$574M
3
AET
Aetna Inc
AET
+$243M
4
CI icon
Cigna
CI
+$187M
5
INTC icon
Intel
INTC
+$178M

Sector Composition

Rank Sector Weight
1 Healthcare 43.25%
2 Materials 14.62%
3 Technology 10.62%
4 Communication Services 9.13%
5 Consumer Discretionary 8.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
HCA icon
1
HCA Healthcare
HCA
$99.8B
$1.3B 8.43%
14,899,289
+634,024
+4% +$53.6M
2013 Q2
16 quarters
FMC icon
2
FMC
FMC
$1.29B
$949M 6.16%
14,980,127
+2,784,127
+23% +$179M
2015 Q1
9 quarters
DD icon
3
DuPont de Nemours
DD
$17.5B
$897M 5.82%
5,614,099
+929,177
+20% +$148M
2014 Q3
11 quarters
IQV icon
4
IQVIA
IQV
$42.9B
$798M 5.18%
8,921,356
+2,023,719
+29% +$171M
2016 Q2
4 quarters
ELV icon
5
Elevance Health
ELV
$92.2B
$762M 4.94%
4,050,631
-661,014
-14% -$119M
2014 Q1
13 quarters
CI icon
6
Cigna
CI
$74.7B
$627M 4.07%
3,743,184
-1,162,244
-24% -$187M
2013 Q2
16 quarters
DXC icon
7
DXC Technology
DXC
$2.04B
$626M 4.06%
+9,430,839
New +$626M
2017 Q2
0 quarters
FLEX icon
8
Flex
FLEX
$41B
$622M 4.04%
50,641,612
+8,868,062
+21% +$110M
2013 Q2
16 quarters
GOOGL icon
9
Alphabet (Google) Class A
GOOGL
$4.33T
$574M 3.72%
12,339,060
-328,300
-3% -$15.4M
2015 Q4
6 quarters
LOW icon
10
Lowe's Companies
LOW
$106B
$513M 3.33%
6,621,609
+1,168,950
+21% +$95.5M
2016 Q4
2 quarters
AET
11
DELISTED
Aetna Inc
AET
$503M 3.26%
3,310,469
-1,718,604
-34% -$243M
2013 Q4
14 quarters
TMO icon
12
Thermo Fisher Scientific
TMO
$245B
$482M 3.12%
2,759,965
-212,095
-7% -$35.6M
2013 Q2
16 quarters
ABBV icon
13
AbbVie
ABBV
$485B
$443M 2.87%
6,110,170
-1,191,797
-16% -$80.1M
2015 Q1
9 quarters
LH icon
14
Labcorp
LH
$25.4B
$411M 2.67%
3,102,046
– –
2015 Q2
8 quarters
PARA icon
15
DELISTED
Paramount Global Class B
PARA
$372M 2.42%
5,840,355
+368,392
+7% +$23.6M
2013 Q2
16 quarters
AAPL icon
16
Apple
AAPL
$4.98T
$364M 2.36%
10,118,784
-2,454,248
-20% -$90.7M
2016 Q3
3 quarters
THC icon
17
Tenet Healthcare
THC
$21.5B
$346M 2.24%
17,890,230
– –
2013 Q2
16 quarters
EBAY icon
18
eBay
EBAY
$51.8B
$311M 2.02%
8,905,922
+7,262,862
+442% +$249M
2016 Q4
2 quarters
SHPG
19
DELISTED
Shire pic
SHPG
$285M 1.85%
1,722,977
+707,500
+70% +$124M
2017 Q1
1 quarter
LBTYA icon
20
Liberty Global Class A
LBTYA
$2.92B
$252M 1.64%
7,853,565
+70,000
+0.9% +$2.24M
2014 Q2
12 quarters
V icon
21
Visa
V
$744B
$249M 1.62%
2,654,993
+543,089
+26% +$50.4M
2016 Q4
2 quarters
UHS icon
22
Universal Health Services
UHS
$10.6B
$241M 1.56%
1,973,545
+259,081
+15% +$30.8M
2016 Q3
3 quarters
BKD icon
23
Brookdale Senior Living
BKD
$2.42B
$224M 1.46%
15,250,718
+520,000
+4% +$7.19M
2014 Q2
12 quarters
FDC
24
DELISTED
First Data Corporation
FDC
$222M 1.44%
12,219,432
+1,500,000
+14% +$25.1M
2016 Q2
4 quarters
CAR icon
25
Avis
CAR
$3.8B
$213M 1.38%
7,798,004
-500,000
-6% -$12.9M
2014 Q1
13 quarters
1
2 3

Similar funds

GCM
Graham Capital Management Rowayton, Connecticut $5.5B AUM 26.66% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $5.49B AUM 56.94% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
MC
Maplelane Capital New York $5.51B AUM 67.92% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
NC
Nicholas Company Milwaukee, Wisconsin $5.47B AUM 16.96% 1-Year Est. Return
EI
EFG International Zurich $5.46B AUM
AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return

Glenview Capital Management's Q2 2017 Portfolio in Review

As of Q2 2017, Glenview Capital Management held 58 positions worth $15.4B, up 2.3% from $15.1B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Glenview Capital Management's Q2 2017 filing shows 6 new, 22 increased, 15 reduced and 6 closed positions. Its largest new stake was DXC Technology: 9,430,839 shares worth $626M. The largest sale was Humana, an estimated $1.04B.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 46% a quarter earlier, followed by Materials and Technology.

  • Glenview Capital Management's largest Q2 2017 buy was DXC Technology: 9,430,839 shares worth $626M.
  • Glenview Capital Management added most to eBay in Q2 2017, an estimated $249M increase.
  • Glenview Capital Management's biggest Q2 2017 reduction was Humana, cutting an estimated $1.04B.
  • Glenview Capital Management fully exited Computer Sciences in Q2 2017, selling an estimated $574M.
  • Glenview Capital Management's ten largest holdings make up 50% of its $15.4B portfolio in Q2 2017.
  • Glenview Capital Management opened 6 new positions and closed 6 in Q2 2017.
  • Glenview Capital Management's portfolio value rose 2.3% quarter-over-quarter to $15.4B.

Based on Glenview Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.